CBSC Company Profile and Key Details

Average 10-day trading volume of 13.67 thousand shares is below the 3-month average of 29.60 thousand, indicating normal recent market interest.

The stock is currently mid-range between its 52-week high and low $0.02 and $0.06. With a market capitalization of about $5.96 million, Cardiac Biotech Solutions Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~2.02). Key stats such as the average daily volume over the past year has been around 9.60 thousand shares, trading with heavier-than-usual volume. Headquartered in Las Vegas, NV, Cardiac Biotech Solutions Inc. operates in the Healthcare sector and the Medical - Instruments & Supplies industry. Led by CEO Charles K. Martin, the company employs approximately 4 people and listed since February 16, 2016. Operating globally through its international subsidiaries, Cardiac Biotech Solutions Inc. delivers advanced products and services for non-invasive, mobile cardiac monitoring.

Our AI price prediction model suggests that CB Scientific, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Cardiac Biotech Solutions Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.02. This means the shares are trading below this model’s fair value.

Valuation shows CB Scientific, Inc. trading at a premium to the broader market with a P/E of -8.18.

CB Scientific, Inc. trades at a P/E ratio of -8.18, slightly below the S&P 500 average, with a price-to-sales ratio of 40.29 and a price-to-book ratio of -2.7 indicating negative book value, which may reflect financial stress. The P/FCF stands at -8.66, also below market averages.